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INTRODUCTION 
 
Satisfying sexual experience is an essential part of all human life. 
Sexual function is our physiologic capacity for desire, arousal and 
orgasm. Sexual dysfunction can be caused by variety of physical and 
psychological causes like ageing process, thriving condition, medical 
illness, psychiatric diseases, drugs. Among the drugs anti hypertensives, 
antihistamines, diuretics, anti depressants, benzodiazepines and 
antipsychotics are the common drugs causing sexual impairment. Sexual 
dysfunction is one of the commonest problem among the common people 
and people suffering from psychiatric diseases and people who are in 
treatment with psychotic medicines. Sexual dysfunction is very rarely 
reported spontaneously by patients, therefore, clinical trials of 
antipsychotic medicine depend on spontaneous reporting by patients to 
assess side effects on sexual dysfunction. 
Studies done so far has revealed significant rate of sexual 
impairment is seen with both atypical and typical antipsychotics and this 
side effect is particularly Important in many ways. It affects their self-
esteem and causes problem for their sexual partners, compromises 
treatment compliance , interferes with their quality of life. 
Sexual dysfunction is one of the commonest problem in mood 
disorders, schizophrenia, and all other psychotic disorders. The reported 
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prevalence of sexual dysfunction is 40 -80% in women and 45-85% in 
men.(3, 4, 5). 
Atypical antipsychotics have been prescribed for treatment of 
schizophrenia now a days. The most common antipsychotics prescribed 
are risperidone, olanzapine, quetiapine, arpiprazole, ziprasidone, and 
amisulphride. 
Atyical antipsychotics have wide range of action over positive, 
negative, affective, and cognitive symptoms of schizophrenia. When 
compared to typical antipsychotics, atypical antipsychotics produce less 
extra pyramidal symptoms like tremos, rigidity, tardive dyskinesia, 
dystonia, neuroleptic malignant syndrome and said to cause least sexual 
side effects. 
Now a days atypical antipsychotics are prescribed not only for 
psychosis or schizophrenia, they are prescribed for mania, bipolar 
disorders, bipolar depression, atypical depression, to control the 
behavioural disturbances in disruptive disorders, mental retardation, and 
treatment resistant depression. 
So inorder to get little sexual side effects as a psychiatrist we must 
get a clear cut knowledge about the sexual side effects produced by 
atypical antipsychotics and which is safe to administer to the patients. 
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The major impact produced on sexual functioning in schizophrenic 
patients is by antipsychotics.There are lot of studies that about sexual 
Dysfunction caused by typical antipsychotics as well as there are 
studies that compared typical and atypical antipsychotic drugs. But, there 
are only a few studies that have compared different atypical antipsychotic 
agents for sexual impairment. There are only few studies in Indian 
population regarding this.,  
Various aspects that make us difficult to assess the sexual function 
related to psychotrophic medications are 
1.  Selection of patients. 
2.  Procedures used for sexual assessment.(directly questioning, 
or self report.) 
3.  Subjective or objective measurements. 
4. Lack of baseline assessment. 
5. Gender differences. 
6. Hard to differentiate effects of psychopathology and effects of 
psychotropic medications. 
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Although there are limitations and biases most of the studies had 
agreed the prevalence of sexual dysfunction in schizophrenic patients 
treated with antipsychotics ranging from 25% to 60%.(1, 2). 
So far, researches done into psychotropic-induced sexual side-
effects suffers from substantial methodologic limitations. Patients tend 
not to talk with their clinician about their sexual life. Psychiatrists and 
other doctors need to take the initiative to talk about the patient's sexual 
life in order to become informed about potential medication-induced 
sexual difficulties. 
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REVIEW OF LITERATURE 
Sexual dysfunction 
Sexual dysfunction prevalence rate has been increasing in both 
men and women. On psychological perspective , According to kaplon and 
master Johnson 4 stages of sexual function is desire, arousal, orgasm 
finaly resolution phase. Alteration in one of this phase leads to sexual 
dysfunction. Sexual dysfunction has significant impact on one’s mood, 
inter personal functioning self esteem, and life satisfaction.{6}. 
It can take many forms –sexual dysfunction means not only limited 
to loss of desire i.e loss of libido. It also includes experiencing pain 
during intercourse., difficulty in maintaining sustained erection, inability 
to experience orgasm. 
Sexual dysfunction in women may be due to vaginal dryness(due 
to low desire, anticipatory anxiety about sex, pain during, intercourse), 
lower libido, and  
Difficulty in achieving orgasm. 
Etiology and pathogenesis 
Sexual dysfunctions are more common but very rarely diagnosed 
and identified by primary care physicians. When we analyse the causes 
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for sexual dysfunction we can broadly classify them as organic and 
psychogenic. 
Organic causes include any chronic illness, pharmacological drugs, 
harmonal imbalances and endocrinological problems, pregnancy, chronic 
hypertension, diabetes mellitus and host of other traumatic, medical, or 
surgical factors.(7). 
Psychogenic causes includes  
1. Iindividual factors (depression, anxiety, fear, frustrations, intra 
psychic conflict, guilt hypo chondriosis). 
2. Iinter personal and relation ship factors, (decreased trust, bad 
communication, relationship conflict, family conflict). 
3.  Sexual enactment factors (unrealistic performance expectations, 
knowledge and skill deficits). 
4.  Psycho sexual factors (performance anxiety, negative learning and 
attitudes, previous sexual trauma, restrictive religiosity, intellectual 
defenses.).(7). 
Psychiatric disorders and sexual dysfunction. 
Sexual problems are highly and commonly seen among in patients 
with psychiatric disorders. It may be due to psychopathology and also as 
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adverse effect of pharmacotherapy. Patients with both positive and 
negative symptoms of schizophrenia, mood disorders exhibit dysfunction 
in desire. arousal and orgasimic phases of sexual cycle. Both typical and 
atypical antipsychotics also cause sexual dysfunction.Patients with 
personality disorders and eating disorders also exhibit sexual 
dysfuction.{8, 9}. 
Sex and schizophrenia 
Sexual functioning has obtained only poor attention as an essential 
aspect of patient care for those suffering from psychiatric disorders such 
as schizophrenia. 
It is one of the essential factor leading to non compliance of 
antipsychotic drugs and is registered by people suffering from 
schizophrenia to be one of the areas of treatment with the most unmet 
needs.(10). 
In early 1900s some of the researchers believed that excessive 
sexual acts and thoughts could be one of the reason for insanity.(11). 
Recently in 1970s psychiatric researchers believed that sexual 
activity could contribute to the development of psychiatric disorders such 
as schizophrenia.(12). 
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Sexual function is affected both qualitatively and quantitatively in 
patients suffering from schizophrenia when compared to the normal 
individuals. 
Schizophrenic patients can also have sexual dysfunction which 
may not be related to drugs and drug effects. 
Studies have proved that even in untreated patients with 
schizophrenia had exhibited sexual dysfunction in the form loss of desire 
for sex. Although their arousal and ejaculatory functions remains intact. 
Especially in females when compared to males but after getting their 
psycho trophic medications They are loosing their arousal and ejaculatory 
functions. (13, 14). 
In studies they have shown that about 50% of schizophrenic 
patients on treatment with conventional antipsychotics reported sexual 
dysfunction.(15, 16). 
And recent studies have reported 80-90% of sexual dysfunction in 
patients of schizophrenia treated with antipsychotics in both sexes.(17). 
  
 9
Patho physiology of antipsychotic induced sexual dysfunction 
The mechanism by which antipsychotics cause sexual dysfunction 
is as follows; 
Dopamine receptor antagonism, Histamine receptor antagonism, 
Dopamine2 receptor antagonism, Cholinergic receptor antagonism. Alpha 
adrenergic receptor antagonism {18}. 
By binding to histamine receptors antipsychotics impair arousal by 
causing sedation. 
By blocking D2 receptors in tubero infundibular pathway, by 
increasing the prolactin level causes impairment in desire, arousal, and 
orgasm indirectly. 
Cholinergic receptor antagonism may cause erectile dysfunction by 
decreasing peripheral vasodilation. 
Alpha-adrenergic alpha receptor antagonism can decrease 
peripheral vasodilation, resulting in decreased lubrication in women and 
erectile dysfunction in men. 
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Role of dopamine on sexual function. 
The dopaminergic structures responsible for sexual motivation are 
the nucleus accumbens, a part of the mesolimbic pathway and the medial 
pre optic region of the hypothalamus. 
Activation of dopaminergic receptors of the paraventricular 
nucleus in the hypothalamus is essential for causing erection. 
Dopamine is the most important hypothalamic prolactin (PRL)-
inhibiting factor. Blocking dopamine secretion leads to 
hyperprolactinemia, which can inhibit sexual function, mainly erection 
and libido by elevating opioids and GABA levels.{19}. 
Dopamine has an inhibiting influence on PRL secretion mainly via 
two pathways: the tuberoinfundibular dopaminergic (TIDA) system and 
the tuberohypophysial pathway.  
Dopamine released into the blood reaches the lactotroph cells and 
binds to the D2R on the membrane of these cells. D2R stimulation inhibits 
the synthesis and release of PROLACTIN, as well as lactotroph 
proliferation. 
PRL regulates tyrosine hydroxylase activity, the rate-limiting 
enzyme in dopamine synthesis. A blockade of D2R counteracts the tonic 
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inhibitory effect on PRL secretion. So, the stronger the dopamine 
blockade, the higher the increase in PRL.{18, 20}. 
ANTI PSYCHOTICS AND HYPERPROLACTENEMIA 
The prolactin is secreted from the anterior pituitary in Pulsatile 
manner and is regulated by inhibitory and stimulatory influences from the 
hypothalamus. There are 12 to 13 peaks per day with an inter pulse 
interval of about 90 min. 
The normal reference values of PRL in the blood are 10–25 ng/mL 
in wo men and 10–20 ng/mL in men.{21} PRL secretion increases during 
sleep and is at its maximum during REM stage sleep. PRL levels increase 
to 30 ng/mL between 4 and 6 in morning. LATEST STUDIES HAVE 
SHOWN that galactorrhea, impotence, azoospermia, and lack of libido 
are noticed when PRL levels are >60 ng/mL.{22} Antipsychotics have a 
D2-blocking effect and can therefore increase PRL secretion. 
Hyperprolactinemia can also cause reduced blood testosterone 
levels and can indirectly lead to reduced sexual activity{19, 20}. 
In females, increased prolactin levels can result in alteration of 
pulse released GnRH and deficiency of estrogen, which results in 
inhibition of menstrual cycle (amenorrhoea). It also causes 
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gynaecomastia, galactorrhoea, and various types of sexual dysfunction, 
especially loss of sexual desire.{23, 24, }. 
A lot of studies on antipsychotic induced sexual dysfunction have 
incorporated the procedure of measuring prolactin level. And most of 
them have found a positive association between hyperprolactinemia and 
sexual impairment. (8, 21, 23, 25, 26, 27, 28, 29). 
When it comes to the proportion of cases where 
hyperprolactinemia was associated with sexual dysfunction, studies infer 
it to be 25-40%. (28, 30). 
On the basis of blocking of dopamine D2 receptors, , risperidone, 
haloperidol and amisulpride are classified as prolactin-elevating 
antipsychotics, while clozapine, quetiapine, ziprasidone, olanzapine and 
aripiprazole are classified as prolactin-sparing drugs.{18}. 
The influence of serotonin and noradrenaline on sexual function. 
Serotonin mainly inhibits sexual function by stimulating 
postsynaptic 5-HT2A and 5-HT2C receptors, while the stimulation of 
presynaptic 5-HT1A autoreceptors increases sexual activity, reducing 
serotonin secretion from the nerve termini.{25, 31, }. 
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Noradrenaline, another neurotransmitter, increases the ability for 
arousal through its influence on central receptors and inhibits erection by 
binding with peripheral α1 receptors.{32}. 
Peripheral influence of antipsychotic drugs 
Adrenergic system is the one of the most important peripheral 
system which have its influence on penile erection beta 2 adrenergic 
activation over sympathetic activation is essential for blood to flow in 
penile and cavernous arteries to produce vaso dialatation and erection. 
(33). Priapism that is prolonged painful erection is also one type of sexual 
disorder reported by patients on atypical antipsychotics. It is caused due 
to blockage of alpha1 adrenegic receptors by atypical antipsychotics. 
studies have shown that olanzapine, risperidone and amisulphride can 
cause priapism.(34). 
A study done by jagadeesan et al have reported irreversible 
priapism in a patient started with olanzapine 5mg per day on the sixth day 
of starting treatment.(35). 
Reversible priapism cases also have been reported in treatment 
with risperidone and ziprasidone. 
Sedative influence by antipsychotics 
We know that antipsychotics produce sedation by blocking H1 
receptors (histaminic), 5HT2A receptors, anticholinergec effects, sedation 
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decreases sexual desire and sexual performance and sexual activity.this 
mechanism play a major role in producing sexual dysfunction. So the 
drug must be administered by knowing their pharmacokinetics and the 
time 6 hours before going to bed should be administered. 
Newer drugs like arpiprazole, ziprasidone, amisulphride do not 
block histaminergic and cholinergic receptors, so they don’t produce 
sedation and also cause only little sexual dysfunction. (36). 
Studies of sexual dysfunction due to antipsychotics in schizophrenia 
The important study done by Kotin and co-workers is one of the 
first studies in this aspect. They studied sexual impairment in eighty 
seven schizophrenic patients. 57 of them were on thioridazine and 
another thirty were on other antipsychotics like chlorpromazine, 
haloperidol trifluperazine, fluphenazine, and thiothixene. Sixty percent of 
thioridazine group reported sexual impairment and twenty five percent of 
those on other groups reported sexual dysfunction. (37). 
Ghadirian and his team studied about sexual impairment and 
prolactin levels in fifty five schizophrenic patients of which 29 were 
females and 26 males. Most of them were taking fluphenazine. Fifty four 
percent of males and thirty percent of females reported sexual 
dysfunction. No placebo controls in this study.(16) 
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In the study done on 20 patients receiving haloperidol or fluphenazine in 
men with schizophrenia, by Burke and his team, 50% reported erectile 
dysfunction. They were receiving either haloperidol or fluphenazine.(38). 
Smith and his team studied sexual dysfunction among 101 patients 
diagnosed as schizophrenia and who are on typical antipsychotics 
(flupenthixol, fluphenazine, thioridazine, trifluoperazine, haloperidol, 
pimozide), 57 normal controls and 55 controls attending a sexual 
dysfunction clinic. They were Assessed on a sexual functioning 
questionnaire designed by smith et al, 45% of patients and 61% of 
controls attending the sexual dysfunction clinic reported sexual 
dysfunction. This study has also compared different typical 
antipsychotics for sexual impairment among both men and women. (39). 
Kockott and Pfeiffer studied sexual disorders in mixed population 
of non acute psychiatric outpatients which included 100 patients of 
schizophrenia, 58 patients of affective Psychosis and 30 patients 
receiving skin treatment, as control group. They were Rated on a 
sexuality questionnaire, 49% of schizophrenics, 36.2% of those with 
mood disorder and 13.3% of controls had a sexual dysfunction.(40). 
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Studies comparing sexual dysfunction due to typical & atypical 
antipsychotics. 
A study by Hummer and his team compared sexual dysfunction 
among schizophrenics on haloperidol with those on clozapine. Fifty three 
patients on halopeidol patients and 100 patients on clozapine (including 
men and women) were selected and they were rated on UKU side effect 
rating scale. interestingly there was no statistically significant difference 
between clozapine and haloperidol with regard to their ability to cause 
sexual impairment.(41). 
A study done by aizenberg and his team compared sexual 
dysfunction only in male schizophrenics on clozapine (N = 30) with those 
on other typical antipsychotics (N = 30) including depot preparation of 
fluphenazine and haloperidol and oral perphenazine. Rated on a sexual 
function questionnaire, significant difference was found in frequency of 
libido, arousal, erections and number of orgasms per month, inferring that 
maintenance therapy with clozapine may be associated with a lesser 
degree of sexual dysfunction than the typical antipsychotics.(42). 
Wirshing and co compared atypical and typical antipsychotics for 
sexual dysfunction in 25 males suffering from schizophrenia and who are 
on treatment with three groups clozapine, risperidone and haloperidol / 
fluphenazine combination, they were Assessed on a sexual functioning 
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questionnaire developed by Burke et al.(1994), the majority of 
risperidone (71%) and haloperidol / fluphenazine (61%) treated subjects 
showed sexual dysfunction but less of clozapine (40%) treated 
subjects.(26) 
Bobes and colleagues studied cross-sectionally sexual dysfunction 
with risperidone, olanzapine, quetiapine and haloperidol among 636 
patients of schizophrenia; assessing them on UKU side effect rating scale. 
Patients selected were on a single antipsychotic drug only. Frequency of 
sexual dysfunction was 35.3% on olanzepine, 43.2% on risperidone, 38% 
on haloperidol and 18.2% on quetiapine group (43). 
Studies comparing different atypical antipsychotics for sexual 
dysfunction 
Knegtering and associates studied about sexual dysfunction on 49 
patients of schizophrenia and other psychotic disorders due to quetiapine 
(200-1200 mg/day) (n=25) and risperidone (1-6 mg/daunctiony) (n=24) 
in a randomized open label study. Assessed on a sexual functioning 
questionnaire, concluded that sexual dysfunction is significantly less 
common in quetiapine than risperidone. (24) 
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Melkersson studied cross-sectionally the degree and frequency of 
prolactin elevation and related symptoms of galactorrhea, amenorrhoea , 
sterility and decreased sexual desire in patients with schizophrenia, 
schizophreniform and schizoaffective disorders who are on clozapine 
(n=28), olanzapine (n=29) and risperidone (n=18). Increased prolactin 
level was found in eighty nine percent of those on risperidone, twenty 
four percent of those on olanzapine and none among those on clozapine. 
Overall, clozapine was found to be the superior agent when compared to 
risperidone and olanzapine, with respect to sexual functioning.(45). 
Montejo and colleagues studied on quetiapine alone, in an open-
label, on 82 patients with a diagnosis of schizophrenia or 
schizophreniform disorder, on quetiapine in a real practice setting, on 
‘Psychotropic-Related Sexual Dysfunction Questionnaire’. The authors 
concluded that quetiapine shows a low frequency of sexual dysfunction 
during prolonged treatment.(46). 
 Atmaca and co-workers studied sexual dysfunction caused by 
quetiapine alone.They evaluated 36 schizophrenic patients on quetiapine 
for 4 weeks and concluded that even quetiapine causes significant sexual 
impairment.(47). 
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Another recent study compared risperidone, olanzapine and 
quetiapine for sexual dysfunction using the questionnaire, Arizona Sexual 
Experience Scale (ASEX). It was a cross-sectional study with a sample 
size of 238 (quetiapine-57, olanzapine-94, risperidone-87). The mean 
scores on ASEX were relatively low in quetiapine group compared to 
olanzapine and risperidone group.(48). 
Indian study done by anil kumar nagaraj and nagesh p.bai A 
comparative study of sexual dysfunction involving risperidone, 
quetiapine, and olanzapine, among 102 patients of schizophrenia found 
there was statistically no significant difference across the study groups 
although it was relatively less with quetiapine.(49). 
Risperidone 
Risperidone is a atypical antipsychotic drug with a high probability 
of causing prolactin elevation. As per cross sectional studies and clinical 
trials, risperidone elevates the serum prolactin up to a level of 30~60 
ng/ml when used at therapeutic doses in a dose dependent manner(50). 
A prospective 5 year observational study evaluating 90wo men and 
128 men reported that risperidone induces a higher prolactin elevation 
when compared to other atypical antipsychotics(51) 
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Evidence from a large prospective observational study showed that 67.8% 
of men and women receiving risperidone for over 1 year reported sexual 
dysfunction.(30).Reduced sexual desire is the most frequently reported 
disturbance. few patients report erectile dysfunction/sexual dysfunction 
and amenorrhea. The rate of sexual dysfunction is significantly high as 
compared with patients those who were receiving olanzapine. 
According to a cross-sectional study studying males and females 
separately total sample of 131, 37.8% of males reported decreased libido, 
32.1% complained erectile and arousal dysfunction, and 32.6% reported 
ejaculatory and orgasmic disorder. In female patients, 40.5% reported 
decreased libido, 19.0% reported arousal disorder, and 15% reported 
vagina l dryness(43). 
A small scale study have shown galactorrhea, gynaecomastia and 
priapism in male patients. Further, female patients were reported to 
experience galactorrhea and amenorhoea.(44). 
Olanzapine 
Olanzapine does not increase the prolactin level permanently. 
Moreover, in many cases, the elevated prolactin level returns to a normal 
level. (52). 
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A 28 week double blind control study done by Hamilton and his 
team among 339 patients and aimed at the efficacy of olanzapine, 
olanzapine produces a low incidence of sexual dysfunction in men as 
compared to men treated with risperidone.(53). 
A 6-month observational study done on first time treated 
schizophrenic patients evaluating sexual functioning among showed that 
the loss of sexual desire was significantly less common in the olanzapine 
group when compared to the risperidone and haloperidol group(54). 
In a randomized open-label comparison of the impact of olanzapine 
versus risperidone on sexual functioning, less sexual dysfunction 
occurred in the group treated with olanzapine (n=20) than the risperidone 
group (n=19),.(27). 
Quetiapine 
In a large population study they have proved that when we use 
quetiapine in a therapeutic dose it was found not associated with the 
increase in prolactin levels.(52). 
In an open-label study, among the patients with schizophrenia or a 
related psychotic illness who were randomized to quetiapine (200~1200 
mg/day) or risperidone (1~6 mg/day) for 6 weeks, sexual dysfunction was 
lower in patients treated with quetiapine (n=25) compared to those treated 
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with risperidone (n=26). Specifically, there was a significant difference in 
decreased libido and impaired arousal(27). 
People with treatment-resistant schizophrenia participated in a 
randomized double-blind 12-week trial of risperidone (4 mg/day), 
quetiapine (400 mg/day), or fluphenazine (12.5 mg/day). Among them 
only quetiapine was found associated with the normalization of prolactin 
levels and had the greatest benefits among these drugs regarding sexual 
functioning; in particular,.(44) Thus, it appears that quetiapine is 
associated with a lower sexual dysfunction rate than risperidone and 
haloperidol. 
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COMPARATIVE STUDY ON EVALUATION OF SEXUAL 
DYSFUNCTION IN PATIENTS TREATED WITH ATYPICAL 
ANTIPSYCHOTICS INVOLVING RISPERIDONE, OLANZAPINE 
AND QUETIAPINE. 
AIM OF THE STUDY 
1. To determine the frequency of sexual dysfunction associated with 
risperidone, olanzapine, and quetiapine. 
2. To compare the frequency of sexual dysfunction associated with 
risperidone, olanzapine, and quetiapine, among patients with 
clinically stable schizophrenia. 
3. To assess the duration of drug intake and its effect on sexual 
function. 
Null hypothesis 
There is no difference in the frequency of sexual dysfunction in 
patients treated with atypical antipsychotics like risperidone, olanzapine, 
and quetiapine. 
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Study design 
It is a cross sectional study. 
Patients are selected through purposive sampling technique. 
Done in 6 months duration from january2015 to june 2015. 
 
CONSENT APPROVAL 
Apart from history, both patients and informants were explained 
about the details of the study and the informed conset was obtained both 
from the patient and the informants in the prescribed format. The 
institutional ethical comiteee’s approval was obtained prior to the study 
and the protocols were followed throughout the study. 
 
Study centre 
Out patient department, institute of mental health.chennai. 
 
 
 
 
  
 25
INCLUSION CRITERIA 
Male and female patients between 18-40 years of age. 
Sexually active. 
On regular treatment with stable doses of risperidone, quetiapine, 
or olanzapine for atleast six weeks after achieving clinical stability. 
EXCLUSION CRITERIA 
Patients having comorbid medical illness. 
Patients with comorbid psychiatric illness. 
Patients with primary sexual dysfunction. 
Those who are on more than one antipsychotic drug or other drug 
affecting sexual function like antidepressants and anti hypertensives. 
Substance abuse. 
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MATERIALS AND METHODS 
the sample for this study is selected from out patient department, 
psychiatry, institute of mental health, chennai. it consists of 75 patients of 
schizophrenia meeting icd 10 criteria and who have attained clinical 
stability. and also 25 healthy volunteers from the care givers of the 
patient and staff of the hospital who were willing to partcipate in the 
study.so the total number of sample is 100. 
This is cross sectional, hospital based study after getting the 
clearance from the local ethical committee clearance, the subjects were 
recruited for the study during january 2015 to june 2015 by purposive 
sampling technique. The sample was divided into four groups. 
group1-----25 healthy volunteers 
group2----25 patients on olanzapine. 
group3----25 patients on quetiapine. 
group4---25 patients on risperidone. 
none of these drugs were not administered for the purpose of the 
study.after getting written consent, the patie nts who were maintaining 
remission with one of these tablets in the oral form of tablets were 
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enrolled into the study during their regular follow up.study related 
assessments were done on the same day of selecting the patients. 
sample consists of both male and female patients between 18-40 years of 
age.  
 
TOOLS USED; 
1. Socio demographic data. 
2. Clinical information sheet. 
3. Brief psychiatric rating scale. 
4. Changes in sexual functioning questionare.(csfq—male 
version) 
5. Changes in sexual functionin g questionare.(csfq—female 
version). 
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Socio demographic data 
Name  
Age  
Sex 
Marital status 
Education 
Employment status 
Monthly income 
Type of family 
Family history 
Past history. 
 
 
 Clinical information sheet. 
Diagnosis made, duration of illness, type of drug in which the patient is 
currently on, years maintaining clinical stability, daily dosage of drugs. 
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Brief psychiatric rating scale. 
First published in 1962 as a 16-construct tool by Drs. John Overall 
and Donald 
Gorham, the developers added two additional items, resulting in 
the 18-item scale used widely today to assess the effectiveness of 
treatment. 
The Brief Psychiatric Rating Scale (BPRS) is a widely used 
instrument for assessing the positive, negative, and affective symptoms of 
individuals who have psychotic disorders, especially schizophrenia. It has 
proven particularly valuable for documenting the efficacy of treatment in 
patients who have moderate to severe disease. 
The BPRS consists of 18 symptom constructs and takes 20-30 
minutes for the interview and scoring. The rater should enter a number 
ranging from 1 (not present) to 7 (extremely severe). 0 is entered if the 
item is not assessed. 
Remisson that is patient maintaining the clinical stability is defined 
as the patients scoring less than 4 in all items of BPRS. 
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CHANGES IN SEXUAL FUNCTIONING QUESTIONARE. 
Changes in sexual functioning questionare (CSFQ) was developed 
with specific versions for males and females to assess sexual functioning 
in all domains of sexual response cycle.it was developed to be used in 
research and clinical settings. 
Csfq-14 version for male and female has 14 items each.scoring is 
done by 0-5 marks per each item and adding the total score. 
For males cut off point to measure sexual dysfunction is at or 
below 47.for females the cut off point is at or below 41. 
This scale has good internal consistency, reliability.the response 
time for csfq-m and csfq-f is 5-10 minutes only.the alpha coefficient for 
csfq-f is 90 and for csfq-m is 89.over 85 studies have been done so far 
with csfq.ove 50 linguistic validated translations were available. 
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Statistical analysis. 
1. Spss software session version 22. 
2. Descriptive statistical analytic study. 
3. Krusakal wallis test. 
4. Chi square tests. 
 
Ethical issues 
1. Written informed consent was taken from all subjects and their care 
givers.only those subjects who agreed to be included after full 
explanation of the requirements of the study were recruited. 
2. The information gathered during the course of the study was kept 
confidential but was shared with treating team if deemed beneficial 
for management of the patient. 
3. All subjects had the right to withdraw from study at any point of 
time as per their will. 
4. The treatment of the patients who refused to participate in the study 
or withdrew from the study after getting enrolled was not 
compromised.  
 32
RESULTS 
Table-1 
Total no of sample-100 
Groups Male Female 
Control group(G1)  13  12 
Olanzapine(G2)  14 11 
Quetiapine(G3)  16 9 
Risperidone(G4) 15 10 
TOTAL 58 42 
 
TABLE-1 SHOWS THE TOTAL NO OF PERSONS 
PARTICIPATED IN THIS STUDY.OUT OF WHICH 25 ARE 
VOLUNTEER HEALTHY CONTROLS AND 75 PATIENTS OF 
SCHIZOPHRENIA, OUT OF WHICH 58 MALES AND 42 
MALES.IN QUETIAPINE GROUP LEAST NUMBER OF 
FEMALES PARTICIPATED. 
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TABLE-2 
Subtype of schizophrenia across the THREE drug groups.(N=75). 
 
FIG-1 
 
Table 2 and fig-1 shows distribution of diagnosis and subtypes of schizophrenia 
among the study sample, across three different groups. paranoid schizophrenia 
is top among the subtypes(46%). 
 
46%
18%
14%
14%
4% 2%
paranoid
unspecified
catatonic
undifferent
hebephrenic4%
simple
 DIAGNOSIS 
 CATATONIC 
SCHIZOPHR
ENIA 
HEBEPHREN
IC 
SCHIZOPHR
ENIA 
PARANOID 
SCHIZOPHRE
NIA 
SIMPLE-
SCHIZOPH
RENIA 
UNDIFFER
ENTIATED 
SCHIZOPH
RENIA 
UNSPECIFI
ED 
G
R
O
U
P 
CONTR
OL 
25 0 0 0 0 0 0 
OLANZA
PINE 
25 4 1 12 0 4 4 
QUETIA
PIN 
25 3 1 12 2 2 5 
RISPERI
DONE 
25 4 1 11 0 5 4 
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Table-3  
 AGE DISTRIBUTION AMONG THE 
SAMPLE(N=100). 
  
 
AGE GROUP NO OF PERSONS 
PERCENTAGE 
% 
 
AGE 
20 TO 25 10 10.00% 
26 TO 30 22 22.00% 
31 TO 35 25 25.00% 
36 TO 40 43 43.00% 
 
Fig- 2. 
 
TABLE 3 and FIG2 SHOWS THE AGE DISTRIBUTION AMONG THE 
STUDY SAMPLE.(N=100).MOST OF THEM (43%) FALLS AGE GROUP 
BETWEEN 36-40.ONLY 10% OF THEM ARE AMON AGE GROUP 20 TO 25 
10%
22%
25%
43%
AGE DISTRIBUTION
20 TO 25 26 TO 30 31 TO 35 36 TO 40
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TABLE -4  
SEX DISTRIBUTION AMONG THE SAMPLE (N=100). 
SEX DISTRIBUTION 
 GROUP Total 
CONTROL 
G1 
OLANZAPINE 
G2 
QUETIAPIN 
G3 
RISPERIDONE 
G4 
SE
X
 M
al
e Count 13 14 16 15 58 
% within SEX 22.4% 24.1% 27.6% 25.9% 100.0% 
Fe
m
al
e Count 12 11 9 10 42 
% within SEX 28.6% 26.2% 21.4% 23.8% 100.0% 
Total Count 25 25 25 25 100 
% within SEX 25.0% 25.0% 25.0% 25.0% 100.0% 
FIG-3 
 
 
22.40%
24.10%
27.60%
25.90%
28.60%
26.20%
21.40%
23.80%
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
CONTROL OLANZAPINE QUETIAPIN RISPERIDONE
SEX DISTRIBUTION
MALE FEMALE
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TABLE 5 LITERACY LEVEL 
 EDUCATION 
BACHELOR 
DEGREE 
(26%) 
HIGH 
SCHOOL 
(35%) 
HIGHER 
SECONDE
RY 
(27%) 
MASTER 
DEGREE 
(2%) 
OTHERS 
(10%). 
GROUP CONTROL 5 9 6 0 5 
OLANZAPINE 7 9 7 1 1 
QUETIAPIN 7 9 7 1 1 
RISPERIDONE 7 8 7 0 3 
 
FIG-4. 
 
 
0.00%
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Results shows out of 100 persons participated in the study 75 
persons are suffering from schizophrenia.25 persons are volunteer healthy 
controls. totally 58 males and 42 females participated in this study.(table-
1).among 75 schizophrenic patients, 35 patients were diagnosed as 
paranoid schizophrenia.3 hebephrenic and 2 simple schizophrenia 
patients also participated in the current study.(table-2.). 
Table-3 shows age distribution of persons participated in this 
study.43% of persons participated in this study belong to age group of 36-
40.10% 0f the sample belongs to age group 20-25.all other belong to age 
group of 25 –35. 
Table-4 and fig-3 shows sex distribution among the sample.totally 
58 males amd 42 females participated in this study.in olanzapine group 
about 11 females and quetiapine 9 females and in risperidone group about 
10 females participated in our study. 
Table -5 and fig-4 shows the literacy level of study groups.most of 
them had finished high school level (35%).27% have crossed higher 
secondary level.others(10%)include those below 10th std. 
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Table - 6 
DOMICILLIARY STATUS AMONG THE GROUPS 
 
RESIDENCE 
RURAL URBAN 
Count N % Count N % 
CONTROL 11 44.00% 14 56.00% 
OLANZAPINE 13 52.00% 12 48.00% 
QUETIAPIN 16 64.00% 9 36.00% 
RISPERIDONE 12 48.00% 13 52.00% 
 
 
TABLE 6 AND CHART 5 SHOWS THE DISTRIBUTION OF THE PLACE OF 
RESIDENCE OF THE SAMPLE STUDIED.MORE OR LESS  
EQUALLY DISTRIBUTED.MORE SAMPLE FROM RURAL AREA (52%) 
AND OTHERS FROM URBAN AREA (48%) 
  
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
CONTROL OLANZAPINE QUETIAPIN RISPERIDONE
fig 5
RURAL URBAN
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TABLE -7 TYPE OF FAMILY (N=100) 
NUCLEAR JOINT LIVING ALONE 
 
  61% 
 
  36% 
 
  3% 
 
 
 
 
TABLE -7 SHOWS THE DISTIBUTION OF TYPE OF FAMILY AMONG 
THE STUDY SAMPLE. MOST OF THE SUBJECTS WERE FROM A 
NUCLEAR FAMILY. 3% OF THE SAMPLE WERE LIVING ALONE. 
 
  
61%
36%
3%
FIGURE-6
NUCLEAR
JOINT
ALONE
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TABLE - 8    
INCOME DISTRIBUTION AMONG STUDY SAMPLE(N=100) 
 
  Count N % 
 
 
MONTHLY INCOME 
LESS THEN 
5000 
29 29.00% 
5001 to 10000 57 57.00% 
10001 toO 15000 7 7.00% 
MORE THEN 
15000 
7 7.00% 
 
 
 
TABLE -8 AND FIGURE -7 SHOWS THE INCOME DISTRIBUTION OF THE 
SAMPLE.MOST OF THE SUBJECTS WERE IN THE MIDDLE INCOME 
GROUP.29% OF THE STUDY SAMPLE EARNED LESS THAN 5000 PER MONTH. 
 
LESS THEN 5000 5001 TO 10000 10001 TO 15000 MORE THEN 15000
29.00%
57.00%
7.00% 7.00%
FIGURE--7
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TABLE-9 
 
CURRENT EMPLOYMENT STATUS  
AMONG STUDY GROUP (N=100) 
 
 
EMPLOYMENT STATUS 
NIL  YES  
Count N % Count N % 
CONTROL 11 44.00% 14 56.00% 
OLANZAPINE 14 56.00% 11 44.00% 
QUETIAPIN 10 40.00% 15 60.00% 
RISPERIDONE 12 48.00% 13 52.00% 
 
FIG—8 
 
  
NIL
YES
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
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EMPLOYMENT STATUS.
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TABLE-10 
FAMILY HISTORY OF PSYCHIATRIC ILLNESS 
 
 
YES 
 
NO 
 
25% 
 
75% 
 
25% OF SAMPLE HAD FAMILY HISTORY OF PSYCHIATRIC ILLNESS. 
 
FIG-9 
 
TABLE-10 SHOWS AND FIG-9. 25% OF SAMPLE HAD 
PSYCHIATRIC ILLNESS.75% OF SAMPLE DID NOT SHOW 
ANY PSYCHIATRIC ILLNESS 
 
25%
75%
FAMILY HISTORY
YES
NO
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Table-11 
 
MEAN AGE OF FOUR GROUPS 
 
 
CONTROL GROUP 
MEAN AND SD 
 
OLANZAPINE GROUP 
MEAN AND SD 
 
QUETIAPINE 
GROUP 
MEAN AND SD 
 
RISPERIDONE 
GROUP 
MEAN AND SD 
 
31.5 + 5.3 
 
33.4 + 5.5 
 
34.0 + 5.9 
 
33.9 + 5.2 
 
OVER ALL MEAN FOR AGE-- 33.2 + 5.4 
 
 
THE MEAN AGE IS 33.2 IN OUR STUDY, AS SAMPLE CONTAINS THE 
AGE GROUP OF 18 TO 40.AND ALL OF THEM ARE MARRIED AND WHO 
ARE SEXUALLY ACTIVE. 
 
TABLE 12--MEAN DAIL Y DOSES OF THE THREE DRUGS 
 
 
OLANZAPINE (MG) 
 
QUETIAPINE(MG) 
 
RISPERIDONE(MG) 
 
12.8 + 4.8 
 
112 + 43.4 
 
5.6 + 2.0 
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THE MEAN DAILY DOSES OF THREE DRUGS WERE FOUND TO BE 
12.8(4.8) MG, 112(43.4) MG, AND 5.6(2.0) MG FOR OLANZAPINE, 
QUETIAPINE, AND RISPERIDONE, RESPECTIVELY. THEIR MEAN 
CHLORPROMAZI NE EQUIVALENT DOSES WERE 256 MG, 149.3MG, 
AND 280MG FOR OLANZAPINE, QUETIAPINE AND RISPERIDONE 
RESPECTIVELY. 
 
TABLE—13. MEAN CHLORPROMAZINE EQUIVALENT  
DOSES FOR THREE DRUGS 
 
OLANZAPINE 
 
QUETIAPINE 
 
RISPERIDONE 
 
256MG 
 
149.3MG 
 
280MG 
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TABLE—14. SEXUAL DYSFUNCTION IN DESIRE DOMAIN 
ACROSS STUDY GROUPS 
DESIRE * GROUP 
 GROUP 
Total 
CONTROL OLANZAPINE QUETIAPIN RISPERIDONE 
D
ES
IR
E 
Y
ES
 
Count 7 16 12 18 53 
% within 
DESIRE 
13.2% 30.2% 22.6% 34.0% 100.0% 
% within 
GROUP 
28.0% 64.0% 48.0% 72.0% 53.0% 
N
O
 
Count 18 9 13 7 47 
% within 
DESIRE 
38.3% 19.1% 27.7% 14.9% 100.0% 
% within 
GROUP 
72.0% 36.0% 52.0% 28.0% 47.0% 
Total 
Count 25 25 25 25 100 
% within 
DESIRE 
25.0% 25.0% 25.0% 25.0% 100.0% 
% within 
GROUP 
100.0% 100.0% 100.0% 100.0% 100.0% 
 
Table - 15 
Chi-Square Tests 
 Value df p VALUE 
Pearson Chi-
Square 
11.361a 3 0.010 
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Table-16 - AROUSAL/ERECTION DYSFUNCTION 
ERECTILE/AROUSAL 
DYSFUNCTION 
GROUP 
Total CONTROL 
G1 
 
OLANZAPINE
G2 
 
QUETIAPIN 
G3 
 
RISPERIDONE 
G4 
 
 YES Count 6 14 11 16 47 
% within 
ERECTION 12.2% 28.6% 22.4% 34.04.% 100.0% 
% within 
GROUP 24.0% 56.0% 44.0% 64.0% 49.0% 
NO Count 19 11 14 7 51 
% within 
ERECTION 37.3% 21.6% 27.5% 13.7% 100.0% 
% within 
GROUP 76.0% 44.0% 56.0% 28.0% 51.0% 
Total Count 25 25 25 25 100 
% within 
ERECTION 25.0% 25.0% 25.0% 25.0% 100.0% 
% within 
GROUP 100.0% 100.0% 100.0% 100.0% 100.0% 
 
Table - 17 
Chi-Square Tests 
 Value df Asymp. Sig. (2-sided) 
Pearson Chi-
Square 
10.856 3 .0125 
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Table-14 and 15 shows the comparison of impairment of sexual 
desire on four groups, among the drug groups, more impairment in desire 
is seen in risperidone group(72%). And olanzapine(G2) shows 64% 
impairment in sexual desire.and 48% of patients in quetiapine group had 
shown impairment in libido.among the control group 28% showed 
impairment in libido. We got a significant pvalue of 0, 006 in this 
chisquare test. 
Table 15 and 16 shows impairment in erection and arousal among 
the study group taking atypical antipsychotics like risperidone, 
olanzapine and quetiapine, among the groups more dysfunction is seen in 
risperidone group (64%) and olanzapine showing 56% impairment in 
arousal and erection domain of sexual stages.quetiapine shown less 
imapairment when compared to olanzapine and risperidone.it showed 
about 44% impairment in arousals.among the control group, we found 
about 24% impairment.  
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Table—18 impairment in ejaculation /  
orgasm among the study groups 
 
EJECULATION / 
0RGASM* GROUP 
GROUP Total 
CONTROL OLANZAPINE QUETIAPIN RISPERIDONE 
EJ
A
C
U
LA
TI
O
N
 Y
ES
 
Count 5 11 8 11 35 
% within 
EJACULATION 
14.3% 31.4% 22.9% 31.4% 100.0% 
% within 
GROUP 
20.0% 44.0% 32.0% 44.0% 35.0% 
N
O
 
Count 20 14 17 14 65 
% within 
EJACULATION 
30.8% 21.5% 26.2% 21.5% 100.0% 
% within 
GROUP 
80.0% 56.0% 68.0% 56.0% 65.0% 
Total Count 25 25 25 25 100 
% within 
EJACULATION 
25.0% 25.0% 25.0% 25.0% 100.0% 
% within 
GROUP 
100.0% 100.0% 100.0% 100.0% 100.0% 
 
TABLE-19 
Chi-Square Tests 
 Value df p VALUE 
Pearson Chi-Square 4.352a 3 0.226 
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TABLE 20. Impairment in Sexual Pleasure 
 
PLEASURE * GROUP 
 GROUP Total 
CONTROL OLANZAPINE QUETIAPIN RISPERIDONE 
PL
EA
SU
R
E 
Y
ES
 
Count 6 14 14 17 51 
% within 
PLEASURE 
11.8% 27.5% 27.5% 33.3% 100.0
% 
% within 
GROUP 
24.0% 56.0% 56.0% 68.0% 51.0% 
N
O
 
Count 19 11 11 8 49 
% within 
PLEASURE 
38.8% 22.4% 22.4% 16.3% 100.0
% 
% within 
GROUP 
76.0% 44.0% 44.0% 32.0% 49.0% 
Total Count 25 25 25 25 100 
% within 
PLEASURE 
25.0% 25.0% 25.0% 25.0% 100.0
% 
% within 
GROUP 
100.0% 100.0% 100.0% 100.0% 100.0
% 
 
TABLE-21 
 
Chi-Square Tests 
 
Value df p VALUE 
Pearson Chi-
Square 
10.684a 3 0.014 
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TABLE-22 Over all sexual impairment among study groups 
 
               SEXUAL DYSFUNCTION * GROUP 
 GROUP Total 
CONTROL OLANZAPINE QUETIAPIN RISPERIDONE 
SE
X
U
A
L 
D
Y
SF
U
N
C
TI
O
N
 
Y
ES
 
Count 5 13 12 15 45 
% within 
TOTAL 
SCORE 
11.1% 28.9% 26.7% 33.3% 100.0%
% within 
GROUP 
20.0% 52.0% 48.0% 60.0% 45.0% 
N
O
 
Count 20 12 13 10 55 
% within 
TOTAL 
SCORE 
36.4% 21.8% 23.6% 18.2% 100.0%
% within 
GROUP 
80.0% 48.0% 52.0% 40.0% 55.0% 
Total Count 25 25 25 25 100 
% within 
TOTAL 
SCORE 
25.0% 25.0% 25.0% 25.0% 100.0%
% within 
GROUP 
100.0% 100.0% 100.0% 100.0% 100.0%
 
TABLE-23 
 
Chi-Square Tests 
 Value df p VALUE 
Pearson Chi-Square 9.172a 3 0.027 
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Table - 24  
comparison of sexual dysfunction among both sexes 
CONTROL GP 
(G1) 
OLANZAPINE 
(G2) 
QUETIAPINE 
(G3) 
RISPERIDONE 
(G4). 
MALE FEMAL
E 
MALE FEMAL
E 
MALE FEMAL
E 
MALE FEMAL
E 
 
15.38
% 
 
25.00
% 
 
57.14
% 
 
45.45
% 
 
50.00
% 
 
44.44
% 
 
66.67
% 
 
50.00
% 
Table-18 shows impairment of ejaculation and orgasm among the 
four study groups.more impairment of ejaculation is seen in both 
olanzapine and risperidone group.quetiapine and control group shares 
32% and 20% respectively.as other domains risperidone causes more 
impairment in this domain also. We got a pvalue of 0.226 which is not 
significant. 
Table—20 shows about the impairment in sexual pleasure among 
the study groups.68% imapairment is seen in risperidone group where as 
quetiapine and olanzapine causes equal impairment(56%) in causing 
imapairment in patients seeking sexual pleasure with a significant 
pvalue.(0.014). 
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Table-22 and 23 shows comparison of overall sexual impairment 
among the study groups, risperidone (60%) being the top among the 
sexual impairment causing drug among the study groups and quetiapine 
being the least(48%) olanzapine causes 52% impairment among its 
patients. Among the controls we got 20% overall impairment.p value 
0.027 which is significant. 
TABLE -24 shows comparison of overall impairment or sexual 
dysfunction among the four groups across both sexes among the control 
group females showed more sexual impairment(25%) when compared to 
males.(15.38%).among the risperidone(G4) group males showed 66.67% 
and females 50% impairment.among the quetiapine group(G3), males 
showed 50% impairment and females 44.44% impairment in overall 
sexual impairment. Olanzapine (G1) group showed 57.14% impairment 
in males and 45.45% impairment in females. 
Table-25 shows comparison of sexual dysfunction in each domains 
on both sexs across four study groups.80% of males on treatment with 
risperidone has lost the desire for sex.60% of females on same group(G4) 
had lost the libido.i.e loss of sexual desire.in olanzapine group (g2) 
71.0% of males and 54.54% of females reported loss of sexual desire. In 
quetiapine group (g3) 50% of males and 44.44% of females reported loss 
of desire.in control group(g1) 23.03% of males and 33% of females 
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reported loss of libido.in erection or arousal domain risperidone 
group(g4) reported more impairment in arousal.males(66.66%) and 60% 
in females. In quetiapine group(g3) 43.75% of males and 44.35% of 
females complained loss of arousal. Among olanzapine group(g2) 
57.14% of males and 54.54% of females reported loss of arousal.in 
ejaculation risperidone and olanzapine shared almost equal impairment 
where as quetiapine showed least. 
Table-25 comparison among each domains across both sexs 
  
IMPAIRMENT 
IN 
 
IMPAIRMENT IN 
 
IMPAIRMENT IN 
 
 
GROUP 
 
DESIRE/LIBIDO 
 
ERECTION/AROUSAL
 
EJACULATION/ORGASM
 
 
 
CONTROL G1 
 
 
 
M
A
LE
 
FE
M
A
LE
 
M
A
LE
 
FE
M
A
LE
 
M
A
LE
 
FE
M
A
LE
 
23.07% 
(3) 
33.33% 
(4) 
23.03% 
(3) 
25.00% 
(3) 
15.38% 
(2) 
25.00% 
(3) 
 
OLANZAPINE 
G2 
71.0% 
(11) 
54.54% 
(5) 
57.14% 
(8) 
54.54% 
(6) 
42.85% 
(6) 
45.45% 
(5) 
 
QUETIAPINE 
G3 
50.00% 
(8) 
44.44% 
(4) 
43.75% 
(7) 
44.43% 
(4) 
31.25% 
(5) 
33.33% 
(3) 
 
RISPERIDONE 
G4 
80.00% 
(12) 
60.00% 
(6) 
66.66% 
(10) 
60.00% 
(6) 
46.66% 
(7) 
50.00% 
(5). 
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Fig--10 
 
 
DESIRE: The chi-square statistic is 1.6099. The p-value is.657157.  
The result is not significant at p<.05 
ERCTION: The chi-square statistic is 0.3516. The p-value is.950052.  
The result is not significant at p<.05 
EJACULATION: The chi-square statistic is 0.6883. The p-value 
is.875953. The result is not significant at p<.05. 
 
 
 
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
MALE FEMALE MALE FEMALE MALE FEMALE
DESIRE ERECTION/AROUSAL EJACULATION/ORGASM
comparison of each domains in sexual 
dysfunction among study groups
CONTROL OLANZAPINE QUETIAPIN RISPERIDONE
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Table-27—comparison of percentage of patients maintaining  
clinical stability among three groups 
 
DURATION OF 
TREATMENT/CLINICAL 
STABILITY 
 
OLANZAPINE 
 
QUETIAPINE 
 
RISPERIDONE 
0-6 MONTHS 7 (28%)  9 (36%)  9 (36%) 
6MONTHS- 1 YR 12(48%)  13 (52%)  10 (40%) 
1YR—1 1/2 YR  3(12%)  1 (4%)  3(12%) 
2 YRS 3(12%)  2 (8%)  3 (12%). 
 
Table-27 shows that 48% of patients are maintaining clinical 
stability for the period of 6 months to 1 year in olanzapine group.52% of 
patients fom quetiapine group falls in 6months to 1 year. Only 6 patients 
in risperidone group. 3patients in quetiapine group and 6 patients 
olanzapine group are maintaining clinical stability beyond 1 year. 
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Table-28 shows effects of duration of treatment and  
sexual dysfunction 
  
olanzapine 
 
quetiapine 
 
Risperidone 
 
 
0-6 months 
 
 
6months -1yr 
 
 
More than 1 yr 
 
 
 14% 
 
 
 50% 
 
 
 100% 
 
 
 33.3% 
 
 
 53.8% 
 
  
 66% 
 
 
 44.4% 
 
 
 60% 
 
 
 83.3% 
 
The chi-square statistic is 3.6216. The p-value is.459633. The 
result is not significant at p <.0 
Table- 28 shows the effect of duration of treatment on sexual 
dysfunction. Patients on treatment more than 1 year among three groups 
showed 66% to 100% sexual impairment. More the years on drugs 
showed more sexual dysfunction.although among the groups p value is 
not significant sexual dysfunction more dependent on duration of 
treatment. 
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DISCUSSION 
 
We cannot make absolutely a person is suffering from sexual 
dysfunction. it may vary from person to person, time to time. Even a 
normal person can exhibit occasional dysfunction moment. They may 
show some variablity in frequency of sexual desire and activity. 
Sexual functioning also depends upon the progression of age 
because of harmonal changes most of the previous studies have included 
the age criteria of the sample as 50 and also to 60 in some studies.as far 
as our study is concerned we have set the age criteria upto the age of 40 
only. and also we have included females also in this study as the previous 
study selected the scale suitable for only males. so we have selected a 
appropriate scale for assesing the sexual dysfunction in females too.  
As far as the scale is concerned we have selected csfq (changes in 
sexual functioning questionare) seperately has 14 items for males and 14 
items for females. 
It has good reliablity and internal consistency the previous study 
done by nagaraj and team(49) have used sexual functioning questionare 
which has mostly true or false questions and some questions may not be 
suitable for females of our culture. proper scoring cannot also be done 
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from this sfq.so we have decided to give csfq which has proper scoring by 
giving grading marks from 1 to 5. 
It has been clearly given the scoring for each domains like 
pleasure, desire, erection or arousal, ejaculation or orgasm with cut off 
values as we know women of our culture cannot speak openly about 
sexual issues, we used female nursing staffs and post graduates to assess 
their sexual function. 
Assesment of sexual dysfunction.there are various scales to 
measure the sexual activity various studies have utilised various scales for 
measuring sexual activity in various domains like desire, pleasure, 
arousal and erection, ejaculation and orgasm. 
The various scales used in various studies are  
Self rating questionare having 6 items for men, 6 items for women 
have been used in the study done by Ghadirian et al. 1982 (16). 
Sexual functioning questionare used by burke et al, 1994 (38) and 
wirshing et al 2002(26) had 15 items that too only for men, so they 
studied sexual dysfunction only in men. 
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Modified sexual functioning questionare was the other one used by 
smith et al2002 (39).which had separate 22 items for men 26 items for 
women. 
Sexual behavior questionare having 11 items for men and 12 items 
for women have been used by mc.donald team(17). 
There are other various scales that have been used in various 
studies. 
Clayton 2002(55) describes criteria for selecting scales for 
assessment of sexual dysfunction arizona sexual experience scale is the 
one which had only 5 items he also says that changes in sexual 
functioning questionare is the appropriate scale which has good internal 
consistency and good reliability even treatment resistance patients can be 
questioned with help of this scale for assessing sexual dysfunction.(Kelly 
et al 2003).(44). 
Csfq -14 has been used in this study which has separate 14 
questions for men and 14 questions for women. 
When we see the socidemographic profile of this study, most of 
them have crossed high school level, and illeterates constituted only less  
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than 9 %.family income of most of them fell between rs.5000 to 
10, 000. (about57%).most of them occupation are agricultural farming 
and self employed.all of them are married about 43%of the study falls in 
the age group of 36 to 40. 
Among 100 samples, 25 of them are healthy volunteers and 75 
schizophrenic patients totally we had 58 males and 42 females…among 
the patients we had 32 females and 43 males majority of them are 
diagnosed as paranoid schizophrenia (46%).out of 75 patients 15 patients 
were maintaining clinical stability beyond one year. Rest of them are 
maintaining stability less than one year. They were assessed by rating 
with bprs scale. Remission was defined by less than score of 4 in all 
items. 
When we compare the sample size to the previous studies, the total 
sample size in our study is 100, where as the study done by 
anilkumar.nagaraj and team it was 102, and there was no significant 
difference in total sample size.we have divided into four groups as it was 
done in same study. 
When we go to previous studies, the total sample in study done by 
knegtering et.al(27) they have selected only 49 patients with 
schizophrenia and study done by melkersson et al(45) they have done 
their study on 75 patients with schizophrenia. 
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Montejo and colleagues (46) had done their study on 82 patients 
with schizophrenia or schizophrenifom disorders, but they have studied 
only the sexual. 
Side effects of quetipine alone. 
A large sample size was taken and studied by Byerly MJ, 
Nakonezny PA, Bettcher BM, during 2006(28) 
They have studied in a total sample of 238 patients with 
schizophrenia and studied the sexual side effects of risperidone.quetipine 
and olanzapine. It was also  
A cross sectional study. 
 
Overall sexual impairment 
Over all impairment includes those who have scored less than or at 
cut off level 47 for males and less than or at cut off point 41 for females. 
Study done by hallward and Ellison (56) have that 10-15% of 
western normal population also suffer from sexual dysfunction. 
In our study overall sexual impairment is seen in 20% of healthy 
volunteers I, e control group.15.38% of males from control group scored 
below cut off points and they showed over all sexual impairment.and 
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interestingly 25% of females too showed overall sexual impairment 
because mostly we say sexual dysfunction is common in men than 
women. 
Study done by smith et al (39) with sexual functioning questionare 
recognised sexual dysfunction in 17% of the normal population i.e people 
without any illness or on any drugs. 
In another study done by anil kumar nagaraj and his team(49), they 
have found 23% of healthy volunteers were suffering from sexual 
dysfunction. 
So comparing other studies the sexual dysfunction amon g the 
healthy volunteers remain more or less same as that of previous studies. 
In our study it has been found that risperidone is associated with 
most frequent overall sexual impairment (60%). Compared to olanzapine 
(52%) and quetiapine(48%) and it was found statistically significant. 
Risperidone was found associated with 60% of overall sexual 
impairment, in males 66.67% and in females it is around 50%. 
Olanzapine has constituted 52% of overall sexual impairment, , 
57.14% of males showed sexual impairment with olanzapine and 45.45% 
of females who are taking olanzapine showed sexual dysfunction. 
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In our study, quetiapine had shown less overall sexual dysfunction 
when compared to other drugs. It had caused 48% of sexual dysfunction. 
50% of males taking quetiapine showed sexual dysfunction and 44.44% 
females showed overall sexual impairment. 
Melkersonn studied about the prolactin elevation due to atypical 
antipsychotics.he concluded that 89% percent of patients showed elevated 
prolactin and showed over all sexual dysfunction.(45). And 24% patients 
on olanzapine also showed prolactin elevation and sexual dysfunction. 
The study done by Kelly DL and conley 2006(44) showed over all 
sexual impairment 42% percent on patients treated with risperidone and 
50% patients treated with quetiapine this study used the same scale csfq 
used in the current study interesting feature in this study is quetiapine had 
overtaken risperidone in the frequency of sexual dysfunction. this showed 
or proved that only prolactin elevation is not the cause for sexual 
dysfunction, there are also other mechanisms driven by antipsychotics for 
causing sexual dysfunction. 
Another recent study done by byerly and his team(28), it was a 
large study done with Arizona sexual experience scale for assessing 
sexual function have shown similar type of overall sexual impairment 
compared to our study. It compared same quetiapine, olanzapine, and 
risperidone and showed that quetiapine group showed a slight lesser 
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degree of sexual dysfunction although it differed significantly only with 
olanzapine group. 
Knegtring and his team (27) has studied in 49 patients with 
schizophrenia comparing sexual function with risperidone and quetiapine 
and has shown that 
50% of sexual dysfunction with risperidone and only 16% of 
patients on quetiapine showed sexual dysfunction.the scale sexual 
functioning questionare was used by him for his study. 
Bobes and colleagues (43) had done their study during 2003 over 
636 patients with schizophrenia.he had done his study with four drugs 
including haloperidol along with quetiapine, risperidone, and 
olanzapine.he reported that 18.3%percent of patients on quetiapine, 
43.2% patients on risperidone showed sexual dysfunction and 35.3% 
patients on olanzapine showed sexual dysfunction. Lesser sexual side 
effects due to quetiapine was presumed to be due to shortterm treatment. 
In the study done by wirshing (26) comparing typical and atypical 
antipsychotics reported 71% sexual dysfunction is caused by risperidone. 
The recent study done by anilkumar nagaraj and his team (49) done 
on 102 patients with schizophrenia assessed with sexual functioning 
questionare used by burke et al team, and they reported sexual 
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dysfunction 96% in patients treated with risperidone and olanzapine 
group showed 90% sexual dysfunction and 88% with quetiapine. This 
study was only done on male patients and age criteria also play important 
role they have included upto age group of 50.it also does not studied 
extensively about the effect of duration of treatment on sexual 
dysfunction. 
But in our study, we have taken both males and females and 
included the samples restricted to the age group upto 40 only to avoid 
biases.and also studied about the effect of duration of drug intake and 
their effect on sexual dysfunction. 
In our study we have got significant change with quetiapine 
showed less sexual dysfunction when compared with olanzapine and 
risperidone.when compared with females, males showed more sexual 
dysfunction over females in all three study groups. 
 
DESIRE 
Impairment in desire is one of the commonest reported sexual 
dysfunction among all medication groups in the current study. 
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It is very difficult to assess the changes in libido caused by 
psychotrophic medications. Because several factors has influence over 
libido. 
Even during the course of psychiatric illness the patient may have 
significant reduction in sexual interest. In symptomatic cases of 
schizophrenia with predominant negative symptoms, the frequency of 
sexual fantasy is much reduced to masturbation.(56).every stages in 
sexual activity has influence over other stages failure of erection affects a 
person’ desire. A patient’s socio economic status and quality of life also 
influence his libido. 
In a study conducted by melkersson(45).he has reported that libido 
was the most frequently complained symptom of sexual dysfunction with 
both haloperidol(58%) and clozapine(50%). 
In another study done by atmaca et al(47), they have reported that 
impaired libido (44%) was the most common sexual dysfunction caused 
by risperidone he also concluded that quetiapine causes impairment of 
libido in 31.6% of males and 28.6% in females  
Gharidian and collegues (16) also have reported sexual dysfunction 
caused by neuroleptics especially impaired sexual desire, significant 
amount of loss of libido has been reported caused by risperidone and 
quetiapine. 
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Anilkumar nagaraj team (49) has reported that impaired libido is 
seen in patients treated with risperidone (80%)., 72% with quetiapine, and 
78% of impaired libido in quetiapine group.  
In our study more impairment in desire is seen with risperidone 
group(72%), and olanzapine group showed 64% of loss of desire, while 
quetiapine group showed 48% impairment in desire. Out of which 80% of 
males, 60% of females of risperidone group complained loss of 
desire.71% of males.54.54% of females in olanzapine group complained 
impairment in libido.and 50% of males in quetiapine group and 44.44% 
of females reported loss of desire in same group.at the same time 28% of 
control group, 23.07% of males and 33.33% of females from healthy 
volunteers also reported loss of sexual desire. 
We get a significant p value of 0.010 as far as desire is concerned, 
we get significant less complaints about loss of desire in quetiapine 
compared to risperidone and olanzapine.our study show results more or 
less comparable to previous studies. It is always difficult to say that the 
drugs alone are responsible for higher rate of impaired sexual desire in 
this study.we cannot exclude the role of illness also playing important 
role in impairment of libido experienced by the patients. Elevated 
prolactin by antipsychotics also play important role in causing loss of 
sexual desire. 
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Arousal /erection 
Erectile dysfunction was the second most common sexual adverse 
effect complained by patients on psychotrophic medications next to loss 
of libido.among the three drugs again risperidone was found associated 
with erectile difficulties.about 64%of patients complained erectile 
dysfunction, among which males about 66.66% and females about 60% 
complained arousal problems. 
In olanzapine group erectile /arousal difficulties were seen in 56% 
of patients.among which 57.14% of males and 54.54% of females 
reported erectile dysfunction and arousal difficulties.among the control 
group, 23.03% of males and 25% of females complained arousal and 
erectile dysfunction. 
Many studies have reported desire to be the most common sexual 
side effect due to antipsychotics.some studies also have inferred that 
erectile dysfunction also has equal common side effect compared to 
libido.because of availability of procedures like measuring nocturnal 
tumescence and penile plethysmography it had become easier to measure 
and quantify erectile dysfunction compared to libido.further more, it was 
easier for the patient to appreciate and complain his erectile difficulties 
compared to diminished libido.we got a significant p value of 0.006 
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comparing three atypical antipsychotics.quetiapine differed significantly 
from both risperidone and olanzapine. 
In study done anilkumar.nagaraj(49) and his team have reported 
50% erectile dysfunction due to olanzapine, 40% with risperidone and 
quetiapine showing 36% of arousal problems.and found it was not 
statistically significant.comparing our study with this study we have 
found little increase in quetiapine and olanzapine group but gross 
difference with risperidone, as it showed 72% of arousal and erectile 
problems.although patients had significant erection they are not able to 
maintain the erection so that they have pleasure in sex.because of this 
problems most of them complained they are not able to achieve sexual 
pleasure as previously before starting the psychotropic medications. 
 
Study done by mc Donald(17) he has concluded that 52% arousal 
difficulties in both males and females.it was conducted as nithdsale 
schizophrenic survey conducted in schizophrenic patients on typical and 
atypical antipsychotics.he found no difference between them. 
 
Gharidian and colleagues (16) have reported 41% patients of 
schizophrenia reporting erectile difficulties. And study done by 
scherbaum (4c) have reported 47% of erectile dysfunction by atypical 
antipsychotics. 
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Another study done on Indian population done by nagaraj a, k and 
his team(57), have reported erectile dysfunction 53% with typical 
antipsychotics and 31% with atypical antipsychotics and it differed 
significantly(p=0.025).however in this study no comprehensive 
questionare was used.the tool used in this study for assessment is UKU 
rating scale.when comparing erectile dysfunction with other studies we 
have found in respect with quetiapine and olanzapine it falls in the range 
that was reported in earlier studies but with risperidone it was found 
higher. 
 
EJACULATION/ORGASM. 
In majority of the studies orgasmic and ejaculatory adverse effects 
were less commonly reported when compared to erection and libido 
problems caused by antipsychotics that too especially with atypical 
antipsychotics.all most each sexual stage depends upon other stages of 
sexual stages.mostly ejaculation problems are associated with erection 
problems so it makes us difficult to assess the ejaculatory problems.even 
though a person’s orgasmic capacity is intact, he may not ejaculate and 
experience orgasmic joy as he cannot achieve complete erection.this 
limitation could not be explained in our study too. 
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When compared to libido and erectile dysfunction, ejaculatory 
imapairment was found less in our study.about 44% patients belonging to 
risperidone group, and 44% on olanzapine group, 32% in quetiapine 
group and 20% belonging to control group showed ejaculatory and 
orgasmic difficulties.no significant value was obtained between the 
groups. 
Among olanzapine group, 42.85% 0f males and 45.45% of females 
reported ejaculatory or orgasmic qualities.females were found slightly 
higher than males. 
In quetiapine group, 31.25% of males and33.35% of females exhibited 
orgasmic and ejaculatory problems. 
Among the control group, 15.38% of males and 25% of females 
exhibited orgasmic difficulties.when we see in all four groups ejaculation 
and orgasmic problems were noted slightly higher in female groups than 
males. 
Quetiapine caused less problems when compared to risperidone 
and olanzapine., both have caused almost equal problems. 
In the study done by anilkumar.nagaraj team(49), they have 
reported ejaculation impairment in 32% of patients on risperidoneand 
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quetipine and 27% in olanzapine group, when compared to present study 
this values were found lesser. 
Wirsching and his team(26) had reported ejaculatory difficulties in 
86% of patients on risperidone compared to clozapine 20%.but the 
sample size was too small and a type2 error was clearly evident. 
 
Kelly and his team(44) have reported that patients on quetiapine 
had less impairment in orgasmic and ejaculation qualities compared to 
risperidone and fluphenazine.but the patients were receiving drugs only 
for 12 weeks. 
 
Sexual pleasure 
When we inquired about the sexual pleasure obtained before and after 
taking antipsychotics, 68% patients on risperidone group have reported 
that their sexual pleasure has decreased to a extent after consuming drugs, 
and 56% in both olanzapine and quetiapine group have reported that they 
are not able to achieve sexual pleasure which they got previously before 
taking drugs. 
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Effects of duration of treatment. 
About 28% patients maintaining clinical stability for 6 months in 
olanzapine group, and 36% in both quetiapine and risperidone groups 
participated in this study. About 48% in olanzapine group.and 52%in 
quetiapine group and 40% in risperidone goup were maintaining clinical 
stability for 6 months to 1 year. 
About 6% of patient in olanzapine group and 3% in quetiapine 
group and 6% in risperidone were maintaining clinical stability.no 
statistically significant value got on effect of duration of treatment on 
sexual dysfunction.among the groups there were no difference found.but 
clinically more the duration of treatment more the sexual impairment 
were seen.among 70 to 80% of patients who were on treatment for more 
than 1 year have exhibited more sexual dysfunction. 
Only 14% of patients on 0- 6 months treatment on olanzapine 
showed sexual dysfunction.but 100% of patients on olanzapine more than 
1year showed sexual impairment. 
Only 33.3% of quetiapine group showed sexual dysfunction within 
6 months of treatment but 66% of patients on quetiapine for more than  
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1yr treatment showed sexual dysfunction.almost it doubled within 
1 year . 
 
treatment.in case of risperidone 44.4% showed impairment within 
6 months but 83% showed whentreatment goes beyond 1 year. So more 
the duration of treatment more the sexual dysfunction is. No previous 
studies had extensively studied about the durational effect on sexual 
dysfunction. 
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CONCLUSION 
 
The results of this study allow some conclusion to be made as to 
which atypical antipsychotics is markedly and significantly safer than 
other as far as sexual side effects are concerned.  
Comparing to risperidone and olanzapine, quetiapine showed 
significant lower sexual side effects males in this study have shown 
slightly higher sexual side effects when compared to females as it also 
Did not differ significantly.  
As each stage of sexual function depends upon other stages, it is 
difficult to say certainly this drug can cause impairment in certain domain 
of sexual stage. Desire is the commonest sexual side effect to get 
impaired in treatment with atypical antipsychotics. 
As there are only very limited studies in Indian culture, however in 
future, such a research with similar methodology should be done an 
attempt should also be made to compare individual drugs at higher and 
lower doses a study of prolactin levels is also a useful complimentary 
procedure also higher the sample size, better the inference the cause for 
less sexual impairment by quetiapine may be due to its minimal effect on 
prolactin level.  
 76
So although there are many mechanism by which antipsychotics 
cause sexual dysfunction, this study proves that hyperprolactinemia plays 
important role in causing sexual impairment. 
Risperidone being the drug causing hyperprolactenemia 
markedly,it causes more impairment in sexual dysfunction in both males 
and females.in this study impairment in ejaculation and orgasm had been 
more when compared to other studies done so far. 
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LIMITATIONS OF THE STUDY 
 
1. This is single contact hospital –based study done to test the 
hypothesis formulated, based on the available literature, and aimed 
at assessing the frequency of sexual dysfunction involving 
risperidone, olanzapine and quetiapine and comparing them. 
Although a cross sectional design is not always the best design for 
such studies, the problem of attrition seen in the prospective studies 
is not an issue here. 
2.  This study did not incorporate the determination of biological 
markers like the serum prolactin level, unlike other studies Such an 
estimation could have further strengthened it. 
3.  Only the clinically stable patients were incorporated with a careful 
assessment on BPRS, as the patients' account is less reliable during 
the symptomatic phase. However, full remission is rarely achieved 
in schizophrenia, especially with respect to negative and cognitive 
symptoms. 
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BRIEF PSYCHIATRIC RATING SCALE (BPRS)
Patient Name  ________________________________________________ Today’s Date __________________
Please enter the score for the term that best describes the patient’s condition.
0 = Not  assessed,  1 = Not present,  2 = Very mild,  3 = Mild,  4 = Moderate,  5 = Moderately severe,  6 = Severe,  
7 = Extremely severe
1. SOMATIC CONCERN
Preoccupation with physical health, fear of physical illness, hypochondriasis.
2. ANXIETY
Worry, fear, over-concern for present or future, uneasiness.
3. EMOTIONAL WITHDRAWAL
Lack of spontaneous interaction, isolation deficiency in relating to others.
4. CONCEPTUAL DISORGANIZATION
Thought processes confused, disconnected, disorganized, disrupted.
5. GUILT FEELINGS
Self-blame, shame, remorse for past behavior.
6. TENSION
Physical and motor manifestations of nervousness, over-activation.
7. MANNERISMS AND POSTURING
Peculiar, bizarre, unnatural motor behavior (not including tic).
8. GRANDIOSITY
Exaggerated self-opinion, arrogance, conviction of unusual power or abilities.
9. DEPRESSIVE MOOD
Sorrow, sadness, despondency, pessimism.
10. HOSTILITY
Animosity, contempt, belligerence, disdain for others.
11. SUSPICIOUSNESS
Mistrust, belief others harbor malicious or discriminatory intent.
12. HALLUCINATORY BEHAVIOR
Perceptions without normal external stimulus correspondence.
13. MOTOR RETARDATION
Slowed, weakened movements or speech, reduced body tone.
14. UNCOOPERATIVENESS
Resistance, guardedness, rejection of authority.
15. UNUSUAL THOUGHT CONTENT
Unusual, odd, strange, bizarre thought content.
16. BLUNTED AFFECT
Reduced emotional tone, reduction in formal intensity of feelings, flatness.
17. EXCITEMENT
Heightened emotional tone, agitation, increased reactivity.
18. DISORIENTATION
Confusion or lack of proper association for person, place or time.
■
■
Score
■
■
■
■
■
■
■
■
■
■
■
■
■
■
■
■
BPRS_Scale.lay  7/17/06  9:41 AM  Page 1
BRIEF PSYCHIATRIC RATING SCALE (BPRS)
Instructions for the Clinician:
The Brief Psychiatric Rating Scale (BPRS) is a widely used instrument for assessing the
positive, negative, and affective symptoms of individuals who have psychotic disorders,
especially schizophrenia.  It has proven particularly valuable for documenting the 
efficacy of treatment in patients who have moderate to severe disease.
It should be administered by a clinician who is knowledgeable concerning psychotic
disorders and able to interpret the constructs used in the assessment.  Also considered 
is the individual's behavior over the previous 2-3 days and this can be reported by the
patient's family.  
The BPRS consists of 18 symptom constructs and takes 20-30 minutes for the inter-
view and scoring.  The rater should enter a number ranging from 1 (not present) to 
7 (extremely severe).  0 is entered if the item is not assessed.
First published in 1962 as a 16-construct tool by Drs. John Overall and Donald
Gorham, the developers added two additional items, resulting in the 18-item scale used
widely today to assess the effectiveness of treatment.
BPRS Scoring Instructions:
Sum the scores from the 18 items.  Record the total score and com-
pare the total score from one evaluation to the next as the measure of
response to treatment.
Overall, JE, Gorham DR: The Brief Psychiatric Rating Scale (BPRS):  recent developments in ascertainment and scaling. Psychopharmacology Bulletin 24:97-
99, 1988.
BPRS_Instructs.lay  7/24/06  11:57 AM  Page 2
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1 SARAVANAN ### 1 AYANAVARAM 10 HIGH SCHOOL YES MARRIED URBAN AUTODRIVER NIL 4.0 5000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 4.0 4  MONTHSRISPERIDON
2 PRABHU ### 1 TRICHY 8 HIGH SCHOOL NIL MARRIED RURAL NIL NIL 8.0 3000.0 NIL NIL JOINT PARANOID SCHIZOPHRENIA 6.0 1 YEAR RISPERIDON
3 KUMAR ### 1 CHENNAI BSC BACHELOR DEGREEYES MARRIED URBAN CLERK YES 3.0 ###### NIL YES NUCLEAR PARANOID SCHIZOPHRENIA 4.0 6  MONTHSRISPERIDON
4 MANIKANDAN ### 1 PUDUKOTTAI 11 HIGHER SECONDERYES MARRIED RURAL COOLIE YES 6.0 3000.0 NIL YES JOINT UNDIFFERENTIATED SCHIZOPHRE 8.0 5  MONTHSRISPERIDON
5 SETHUMADAVAN ### 1 PAPANASAM 12 HIGHER SECONDERYES MARRIED RURAL TAILOR YES 2.0 6000.0 NIL NIL NUCLEAR UNDIFFERENTIATED SCHIZOPHRE 6.0 2 YEARS RISPERIDON
6 RASU ### 1 SENGOTTAI 9 HIGH SCHOOL NIL MARRIED RURAL FARMER NIL 5.0 7000.0 YES NIL JOINT UNSPECIFIED 4.0 14 MONTHSRISPERIDON
7 PRATHAP ### 1 CHENNAI B.E BACHELOR DEGREEYES MARRIED URBAN ENGINEER NIL 7.0 ###### NIL YES JOINT UNSPECIFIED 4.0 4  MONTHSRISPERIDON
8 MATHIVANAN ### 1 ARUPPUKOTTAI12 HIGHER SECONDERYES MARRIED RURAL COOLIE NIL 4.0 4000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 10.0 8  MONTHSRISPERIDON
9 ASHAD ### 1 CHENNAI B.A BACHELOR DEGREEYES MARRIED URBAN MANAGER YES 7.0 ###### YES NIL JOINT CATATONIC SCHIZOPHRENIA 6.0 6  MONTHSRISPERIDON
10 ROHIT ### 1 CHENNAI BBA BACHELOR DEGREENIL MARRIED URBAN ACCOUNTANT YES 4.0 ###### NIL NIL NUCLEAR UNSPECIFIED 8.0 2 YEARS RISPERIDON
11 SENTHIL ### 1 ARAKKONAM B.COM BACHELOR DEGREEYES MARRIED RURAL ACCOUTANT YES 8.0 ###### NIL NIL JOINT PARANOID SCHIZOPHRENIA 6.0 1 YEAR RISPERIDON
12 MAHADEVAN ### 1 COIMBATORE I.T.I OTHERS YES MARRIED URBAN FITTER YES 9.0 8000.0 YES YES JOINT PARANOID SCHIZOPHRENIA 10.0 5  MONTHSRISPERIDON
13 MOHAMMED ### 1 TRICHY B.E BACHELOR DEGREEYES MARRIED RURAL ENGINEER NIL 2.0 8000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 4.0 1 YEAR RISPERIDON
14 ALEXANDAR ### 1 VILLUPURAM 10 HIGH SCHOOL NIL MARRIED RURAL NIL NIL 4.0 8500.0 NIL YES NUCLEAR UNDIFFERENTIATED SCHIZOPHRE 6.0 11 MONTHSRISPERIDON
15 ALBERT ### 1 TINDIVANAM 1.T.I OTHERS YES MARRIED RURAL FITTER YES 4.0 6000.0 NIL NIL NUCLEAR CATATONIC SCHIZOPHRENIA 4.0 8  MONTHSRISPERIDON
16 ROHINI ### 2 CHENNAI 8 HIGH SCHOOL NIL MARRIED URBAN NIL NIL 5.0 5000.0 NIL YES JOINT PARANOID SCHIZOPHRENIA 4.0 6  MONTHSRISPERIDON
17 KAMALA ### 2 CHENGALPET 10 HIGH SCHOOL NIL MARRIED RURAL NIL NIL 3.0 4000.0 NIL NIL NUCLEAR UNDIFFERENTIATED SCHIZOPHRE 6.0 2 YEARS RISPERIDON
18 ROSE MARY ### 2 SALEM D.PHARM OTHERS YES MARRIED RURAL PHARMACIST YES 3.0 7000.0 NIL NIL NUCLEAR CATATONIC SCHIZOPHRENIA 2.0 10 MONTHSRISPERIDON
19 SALEEMA ### 2 CHENNAI 10 HIGH SCHOOL NIL MARRIED URBAN NIL NIL 4.0 6000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 4.0 2 YEARS RISPERIDON
20 PRABHA ### 2 CHENNAI 11 HIGHER SECONDERNIL MARRIED URBAN NIL NIL 7.0 ###### NIL YES JOINT HEBEPHRENIC SCHIZOPHRENIA 6.0 8  MONTHSRISPERIDON
21 PRAVEENA ### 2 CHENNAI 12 HIGHER SECONDERNIL MARRIED URBAN HOUSEWIFE NIL 3.0 6000.0 NIL NIL NUCLE UNDIFFERENTIATED SCHIZOPHRE 4.0 5  MONTHSRISPERIDON
22 PRIYA ### 2 THIRUVANN 12 HIGHER SECONDERNIL MARRIED URBAN NIL NIL 3.0 ###### NIL NIL NUCLEAR UNSPECIFIED 8.0 4  MONTHSRISPERIDON
23 BANU ### 2 SALEM 12 HIGHER SECONDERNIL MARRIED URBAN NIL NIL 7.0 8000.0 NIL NIL JOINT PARANOID SCHIZOPHRENIA 6.0 2 YEARS RISPERIDON
24 RAJKUMARI ### 2 NEYVELI 8 HIGH SCHOOL NIL MARRIED RURAL NIL NIL ### ###### NIL YES JOINT CATATONIC SCHIZOPHRENIA 4.0 7  MONTHSRISPERIDON
25 revathi ### 2 chennai bba BACHELOR DEGREEyes MARRIED urban NIL NIL 3.0 ###### NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 6.0 7  MONTHSRISPERIDON
26 SANTHANAM ### 1 ERODE 8 HIGH SCHOOL YES MARRIED RURAL COOLIE YES 3000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 10.0 8  MONTHSOLANZAPINE
27 ARUMUGAM ### 1 CHENNAI 12 HIGHER SECONDERYES MARRIED URBAN AUTODRIVER YES 6000.0 NIL NIL NUCLEAR UNDIFFERENTIATED SCHIZOPHRE 15.0 1 YEAR OLANZAPINE
28 SENTHIL ### 1 THIRUVARUR B.A BACHELOR DEGREENIL MARRIED RURAL NIL NIL 5000.0 NIL YES JOINT UNSPECIFIED 10.0 6  MONTHSOLANZAPINE
29 KARIKALAN ### 1 TRICHY 10 HIGH SCHOOL YES MARRIED RURAL BUSINESS NIL 7000.0 NIL NIL JOINT PARANOID SCHIZOPHRENIA 5.0 1 YEAR OLANZAPINE
30 PRABHU ### 1 SALEM 11 HIGHER SECONDERYES MARRIED RURAL BUSINESS YES 6000.0 YES YES JOINT PARANOID SCHIZOPHRENIA 10.0 9  MONTHSOLANZAPINE
31 MANOHAR ### 1 CHENNAI 6 HIGH SCHOOL YES MARRIED URBAN DRIVER YES 5500.0 NIL NIL NUCLEAR UNSPECIFIED 20.0 7  MONTHSOLANZAPINE
32 IBRAHIM ### 1 CHENNAI B.B.A BACHELOR DEGREENIL MARRIED URBAN ACCOUNTANT NIL 8000.0 NIL NIL JOINT CATATONIC SCHIZOPHRENIA 10.0 6  MONTHSOLANZAPINE
33 RAMESH ### 1 CHENNAI B.SC BACHELOR DEGREEYES MARRIED URBAN CLERK YES ###### NIL NIL NUCLEAR UNDIFFERENTIATED SCHIZOPHRE 10.0 2 YEARS OLANZAPINE
34 RAJSEKAR ### 1 chennai B.COM BACHELOR DEGREEYES MARRIED URBAN COOLIE YES 7000.0 NIL YES NUCLEAR PARANOID SCHIZOPHRENIA 15.0 14 MONTHSOLANZAPINE
35 SUBRAMANI ### 1 VILLUPURAM 12 HIGHER SECONDERNIL MARRIED RURAL COOLIE NIL 2000.0 NIL NIL JOINT UNDIFFERENTIATED SCHIZOPHRE 5.0 4   MONTHOLANZAPINE
36 PANDIAN ### 1 CHENNAI 10 HIGH SCHOOL NIL MARRIED RURAL NIL NIL 3000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 10.0 2 YEARS OLANZAPINE
37 SAKTHIVEL ### 1 CHENNAI 12 HIGHER SECONDERNIL MARRIED URBAN NIL NIL 4000.0 NIL NIL JOINT HEBEPHRENIC SCHIZOPHRENIA 15.0 1 YEAR OLANZAPINE
38 RAMAR ### 1 CHIDAMBARAM 7 HIGH SCHOOL NIL MARRIED RURAL BUSINESS NIL 5000.0 NIL NIL NUCLEAR UNSPECIFIED 20.0 16 MONTHSOLANZAPINE
39 MANI ### 1 CHENNAI 10 HIGH SCHOOL YES MARRIED URBAN PHARMACY NIL ###### NIL YES NUCLEAR PARANOID SCHIZOPHRENIA 15.0 8   MONTHOLANZAPINE
40 PRIYADARSHINI ### 2 CHENNAI M.SC MASTER DEGREE YES MARRIED URBAN NIL YES ###### YES NIL NUCLEAR PARANOID SCHIZOPHRENIA 20.0 7   MONTHOLANZAPINE
41 REVATHY ### 2 TRICHY 10 HIGH SCHOOL NIL MARRIED URBAN NIL NIL 5000.0 YES YES NUCLEAR CATATONIC SCHIZOPHRENIA 10.0 4   MONTHOLANZAPINE
42 ARCHANA ### 2 CHENNAI 11 HIGHER SECONDERNIL MARRIED RURAL NIL NIL 3000.0 NIL NIL JOINT UNDIFFERENTIATED SCHIZOPHRE 5.0 3   MONTHOLANZAPINE
43 PANDIAMMAL ### 2 CHENNAI 1O HIGH SCHOOL NIL MARRIED URBAN NIL NIL 7000.0 NIL NIL JOINT UNSPECIFIED 15.0 2 YEARS OLANZAPINE
44 PARVATHY ### 2 NEYVELI 12 HIGHER SECONDERNIL MARRIED RURAL TEACHER NIL 8000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 10.0 18 MONTHSOLANZAPINE
45 SELV I ### 2 MADURAI B.A BACHELOR DEGREEYES MARRIED URBAN TEACHER YES ###### YES NIL NUCLEAR PARANOID SCHIZOPHRENIA 20.0 1 YEAR OLANZAPINE
46 CHANDRA ### 2 VELLORE B.SC BACHELOR DEGREEYES MARRIED RURAL NIL YES 6000.0 NIL NIL NUCLEAR CATATONIC SCHIZOPHRENIA 15.0 6  MONTHSOLANZAPINE
47 VELLAMAL ### 2 VELLORE D.TED OTHERS NIL MARRIED RURAL NIL NIL 6000.0 NIL YES NUCEAR PARANOID SCHIZOPHRENIA 15.0 1 YEAR OLANZAPINE
48 KALA ### 2 CHENNAI B.COM BACHELOR DEGREENIL MARRIED RURAL NIL NIL ###### NIL NIL JOINT PARANOID SCHIZOPHRENIA 10.0 8  MONTHSOLANZAPINE
49 PARVATHY ### 2 TRICHY 10 HIGH SCHOOL NIL MARRIED RURAL NIL NIL 6000.0 NIL NIL JOINT CATATONIC SCHIZOPHRENIA 10.0 6  MONTHSOLANZAPINE
50 ANDAAL ### 2 CHENNAI 12 HIGHER SECONDERNIL MARRIED URBAN NIL NIL 7000.0 NIL NIL JOINT PARANOID SCHIZOPHRENIA 20.0 8  MONTHSOLANZAPINE
51 VIGNESH ### 1 CHENNAI BE BACHELOR DEGREEYES MARRIED URBAN  YES ###### NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 50.0 6  MONTHSQUETIAPIN
52 VICTOR ### 1 CHENNAI 12 HIGHER SECONDERYES MARRIED URBAN  YES 5000.0 NIL NIL JOINT PARANOID SCHIZOPHRENIA 100.0 8  MONTHSQUETIAPIN
53 PAULRAJ ### 1 ARIYALUR 8 HIGH SCHOOL YES MARRIED RURAL  NIL 2000.0 NIL YES NUCLEAR CATATONIC SCHIZOPHRENIA 125.0 5  MONTHSQUETIAPIN
54 KARTHIKEYAN ### 1 CHENNAI B.COM BACHELOR DEGREEYES MARRIED URBAN  YES ###### NIL YES NUCLEAR PARANOID SCHIZOPHRENIA 100.0 1 YEAR QUETIAPIN
55 MANIKANDAN ### 1 TRINELVELI 10 HIGH SCHOOL YES MARRIED RURAL  NIL 5000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 50.0 9  MONTHSQUETIAPIN
56 RAJARAJAN ### 1 CHEYYAR B.A BACHELOR DEGREEYES MARRIED RURAL  NIL 6000.0 NIL NIL JOINT CATATONIC SCHIZOPHRENIA 75.0 2 YEARS QUETIAPIN
57 VISWANATHAN ### 1 SALEM 12 HIGHER SECONDERNIL MARRIED URBAN  NIL 5000.0 YES NIL JOINT UNSPECIFIED 100.0 1 YEAR QUETIAPIN
58 MANICKAM ### 1 PERAMBALUR 8 HIGH SCHOOL NIL MARRIED RURAL  NIL 3000.0 NIL NIL NUCLEAR SIMPLE-SCHIZOPHRENIA 125.0 10 MONTHSQUETIAPIN
59 PRATHAP ### 1 VELLORE 12 HIGHER SECONDERNIL MARRIED RURAL  NIL 6000.0 NIL YES NUCLEAR HEBEPHRENIC SCHIZOPHRENIA 100.0 2 YEARS QUETIAPIN
60 MOHAMMED ### 1 ARAKKONAM 10 HIGH SCHOOL YES MARRIED RURAL  YES 5000.0 NIL NIL JOINT PARANOID SCHIZOPHRENIA 75.0 11 MONTHSQUETIAPIN
61 KARTHIKEYAN ### 1 THIRUVALLUR 10 HIGH SCHOOL YES MARRIED RURAL  NIL 9000.0 NIL NIL NUCLEAR UNDIFFERENTIATED SCHIZOPHRE 150.0 6   MONTHQUETIAPIN
62 MURALI ### 1 CHENNAI 12 HIGHER SECONDERYES MARRIED URBAN  NIL ###### NIL YES NUCLEAR UNSPECIFIED 75.0 5   MONTHQUETIAPIN
63 PAULSAMY ### 1 CHENNAI 12 HIGHER SECONDERYES MARRIED URBAN  NIL 3500.0 NIL NIL JOINT PARANOID SCHIZOPHRENIA 150.0 9   MONTHQUETIAPIN
64 PARTHASARATHY ### 1 AATHUR B.COM BACHELOR DEGREEYES MARRIED RURAL  YES ###### NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 200.0 6   MONTHQUETIAPIN
65 AMIR ### 1 TINDIVANAM B.B.A BACHELOR DEGREEYES MARRIED RURAL  YES 5000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 200.0 14 MONTHSQUETIAPIN
66 MANOHAR ### 1 VELLORE 10 HIGH SCHOOL YES MARRIED RURAL  NIL 3000.0 NIL NIL NUCLEAR UNDIFFERENTIATED SCHIZOPHRE 150.0 11 MONTHSQUETIAPIN
67 KALEESWARI ### 2 CHENNAI 8 HIGH SCHOOL NIL MARRIED URBAN  NIL 3000.0 NIL NIL NUCLEAR PARANOID SCHIZOPHRENIA 100.0 1 YEAR QUETIAPIN
68 ROSEMARY ### 2 TINDIVANAM 12 HIGHER SECONDERNIL MARRIED RURAL  NIL 2000.0 NIL NIL JOINT UNSPECIFIED 75.0 5   MONTHQUETIAPIN
69 KAVITHA ### 2 THIRUVALLUR M.A MASTER DEGREE YES MARRIED RURAL  YES 8500.0 NIL YES NUCLEAR PARANOID SCHIZOPHRENIA 125.0 1 YEAR QUETIAPIN
70 PAAVITHRA ### 2 VELLORE B.A BACHELOR DEGREEYES MARRIED RURAL  YES ###### NIL NIL NUCLEAR CATATONIC SCHIZOPHRENIA 75.0 3   MONTHQUETIAPIN
71 ANJUGAM ### 2 NEYVELI 10 HIGH SCHOOL NIL MARRIED RURAL  NIL 4000.0 NIL YES JOINT PARANOID SCHIZOPHRENIA 100.0 5   MONTHQUETIAPIN
72 RAJESHWARI ### 2 CHIDAMBARAM 8 HIGH SCHOOL NIL MARRIED RURAL  NIL 3000.0 NIL YES NUCLEAR UNSPECIFIED 75.0 8   MONTHQUETIAPIN
73 LALITHA ### 2 PERAMBALUR 12 HIGHER SECONDERNIL MARRIED RUAL  NIL 5000.0 YES NIL JOINT SIMPLE-SCHIZOPHRENIA 100.0 1 YEAR QUETIAPIN
74 SAVITHRI ### 2 CHENNAI D,PHARM OTHERS NIL MARRIED URBAN  NIL 2000.0 NIL N IL NUCLEAR PARANOID SCHIZOPHRENIA 125.0 3   MONTHQUETIAPIN
75 LOHESWARI ### 2 COIMBATORE B,SC BACHELOR DEGREENIL MARRIED URBAN  NIL 6000.0 NIL NIL JOINT UNSPECIFIED 200.0 1 YEAR QUETIAPIN
76 SOMU ### 1 CHENNAI 12 HIGHER SECONDERYES MARRIED URBAN  YES 5000.0 NIL NIL NUCLEAR   CONTROL
77 PRABUSANKAR ### 1 CHENNAI B.A BACHELOR DEGREEYES MARRIED URBAN  YES 9000.0 NIL NIL NUCLEAR   CONTROL
78 RATHORE ### 1 DELHI B.B.A BACHELOR DEGREEYES MARRIED URBAN  YES ###### NIL YES NUCLEAR   CONTROL
79 MUNIAN ### 1 VILLUPURAM 8 HIGH SCHOOL NIL MARRIED RURAL  NIL 1000.0 NIL NIL JOINT   CONTROL
80 PANEERSELVAM ### 1 SALEM 8 HIGH SCHOOL YES MARRIED RURAL  YES 4000.0 NIL NIL JOINT   CONTROL
81 SENTHIL ### 1 CHENNAI D.NURSINGOTHERS YES MARRIED URBAN  YES ###### NIL NIL NUCLEAR   CONTROL
82 PRAKASH ### 1 ERODE D.PHARM OTHERS YES MARRIED RURAL  YES 8500.0 NIL NIL NUCLEAR   CONTROL
83 ASHOK KUMAR ### 1 CHENNAI B.SC BACHELOR DEGREEYES MARRIED URBAN  YES 8000.0 NIL NIL NUCLEAR   CONTROL
84 SUNIL ### 1 CHENNAI 12 HIGHER SECONDERYES MARRIED URBAN  YES 7000.0 NIL YES JOINT   CONTROL
85 ADHIMOOLAM ### 1 VELLORE 10 HIGH SCHOOL YES MARRIED RURAL  YES ###### NIL YES NUCLEAR   CONTROL
86 BABU ### 1 chidambaram d,ted OTHERS yes MARRIED RURAL  NO 7000.0 NIL NIL JOINT   CONTROL
87 PREMKUMAR ### 1 VELLORE D.TED OTHERS NIL MARRIED RURAL  NO 3000.0 NIL NIL JOINT   CONTROL
88 ANAND KUMAR ### 1 CHENNAI D.NURSINGOTHERS YES MARRIED URBAN  YES 7500.0 NIL YES NUCLEAR   CONTROL
89 SASIKALA ### 2 CHENNAI 12 HIGHER SECONDERYES MARRIED URBAN  YES 5000.0 NIL NIL NUCLEAR   CONTROL
90 MOHANA ### 2 ARIYALUR 10 HIGH SCHOOL NIL MARRIED RURAL  NO 4000.0 NIL NIL NUCLEAR   CONTROL
91 PRIYA ### 2 SALEM 12 HIGHER SECONDERNIL MARRIED RURAL  NO ###### NIL NIL NUCLEAR   CONTROL
92 RAJI ### 2 CHENNAI 10 HIGH SCHOOL NIL MARRIED URBAN  NIL 6000.0 NIL NIL NUCLEAR   CONTROL
93 LALITHA ### 2 THIRUVALLUR B.A BACHELOR DEGREEYES MARRIED RURAL  NIL 8000.0 NIL NIL NUCLEAR   CONTROL
94 ARRUNA ### 2 CHENNAI 8 HIGH SCHOOL NIL MARRIED URBAN  NIL 7000.0 NIL NIL NUCLEAR   CONTROL
95 VIJIALAKSMI ### 2 BOMBAY 10 HIGH SCHOOL NIL MARRIED URBAN  NIL ###### NIL NIL NUCLEAR   CONTROL
96 PRASANTHINI ### 2 CHENNAI B.B.A BACHELOR DEGREEYES MARRIED URBAN  NIL ###### NIL NIL JOINT   CONTROL
97 JALIMA BEGAUM ### 2 ERODE 12 HIGHER SECONDERNIL MARRIED RURAL  NIL ###### NIL NIL JOINT   CONTROL
98 SHENBAGAM ### 2 SENGENI 10 HIGH SCHOOL NIL MARRIED URBAN  NIL 8000.0 NIL NIL JOINT   CONTROL
99 VIJAYA ### 2 VELLORE 12 HIGHER SECONDERNIL MARRIED URBAN  NIL 6000.0 NIL NIL NUCLEAR   CONTROL
100 KAMALI ### 2 GUDIYATHAM 10 HIGH SCHOOL NIL MARRIED RURAL  NIL 7500.0 NIL NIL NUCLEAR   CONTROL
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